PROBLEM: Pre-implantation factor (PIF), a small, embryo-derived peptide is detected in the maternal serum prior to implantation and is associated with successful pregnancy outcome. However, its identity is not known. METHOD OF STUDY: PIF was isolated from mouse embryo conditioned media and from pregnant porcine sera, using high-performance liquid chromatography (HPLC) followed by mass spectrometry. RESULTS: Conditioned culture media was separated by gel filtration chromatography followed by reversed phase chromatography. At each step, PIF activity was determined by the lymphocyte/platelet binding autorosette assay (LPBA). Mass spectrometry yielded a single peak with a mass of 1300 Da. The peptide is, however, present in very low concentrations (fM), which has so far precluded complete identification. Pregnant porcine sera that exhibit potent PIF activity were deproteinated by acetone and further fractionated by reversed phase HPLC. Active fractions contain peptides of molecular masses 523 and 551 Da. CONCLUSION: PIF, likely to be peptides, represents a novel substance related to pregnancy initiation and maintenance.
PROBLEM: Pre-implantation factor (PIF), a small, embryo-derived peptide is detected in the maternal serum prior to implantation and is associated with successful pregnancy outcome. However, its identity is not known. METHOD OF STUDY: PIF was isolated from mouse embryo conditioned media and from pregnant porcine sera, using high-performance liquid chromatography (HPLC) followed by mass spectrometry. RESULTS: Conditioned culture media was separated by gel filtration chromatography followed by reversed phase chromatography. At each step, PIF activity was determined by the lymphocyte/platelet binding autorosette assay (LPBA). Mass spectrometry yielded a single peak with a mass of 1300 Da. The peptide is, however, present in very low concentrations (fM), which has so far precluded complete identification. Pregnant porcine sera that exhibit potent PIF activity were deproteinated by acetone and further fractionated by reversed phase HPLC. Active fractions contain peptides of molecular masses 523 and 551 Da. CONCLUSION:PIF, likely to be peptides, represents a novel substance related to pregnancy initiation and maintenance.
Authors: Michael J Paidas; Graciela Krikun; S Joseph Huang; Richard Jones; Michael Romano; Jack Annunziato; Eytan R Barnea Journal: Am J Obstet Gynecol Date: 2010-05 Impact factor: 8.661
Authors: Michael Feichtinger; Eytan R Barnea; Atunga Nyachieo; Mats Brännström; S Samuel Kim Journal: J Assist Reprod Genet Date: 2017-11-11 Impact factor: 3.412
Authors: Christina M Duzyj; Eytan R Barnea; Min Li; S Joseph Huang; Graciela Krikun; Michael J Paidas Journal: Am J Obstet Gynecol Date: 2010-08-12 Impact factor: 8.661
Authors: Christopher W Stamatkin; Roumen G Roussev; Mike Stout; Victor Absalon-Medina; Sivakumar Ramu; Chelsi Goodman; Carolyn B Coulam; Robert O Gilbert; Robert A Godke; Eytan R Barnea Journal: Reprod Biol Endocrinol Date: 2011-05-15 Impact factor: 5.211
Authors: Eytan R Barnea; David M Lubman; Yan-Hui Liu; Victor Absalon-Medina; Soren Hayrabedyan; Krassimira Todorova; Robert O Gilbert; Joy Guingab; Timothy J Barder Journal: PLoS One Date: 2014-07-01 Impact factor: 3.240
Authors: Giuseppe Migliara; Martin Mueller; Alessia Piermattei; Chaya Brodie; Michael J Paidas; Eytan R Barnea; Francesco Ria Journal: Oncotarget Date: 2017-03-28